2.60
전일 마감가:
$2.59
열려 있는:
$2.6
하루 거래량:
34,416
Relative Volume:
0.64
시가총액:
$79.65M
수익:
$6.21M
순이익/손실:
$-19.92M
주가수익비율:
-2.4762
EPS:
-1.05
순현금흐름:
$-16.76M
1주 성능:
+0.00%
1개월 성능:
-5.11%
6개월 성능:
+4.42%
1년 성능:
+24.40%
InspireMD Inc. Stock (NSPR) Company Profile
명칭
InspireMD Inc.
전화
972 3 6917691
주소
4 Menorat Hamaor Street, Tel Aviv
NSPR을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
NSPR
InspireMD Inc.
|
2.60 | 79.65M | 6.21M | -19.92M | -16.76M | -1.05 |
![]()
ABT
Abbott Laboratories
|
129.89 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
93.58 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
339.59 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
81.80 | 104.89B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
69.20 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2016-01-07 | 개시 | Rodman & Renshaw | Buy |
2015-03-13 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2013-11-26 | 개시 | Oppenheimer | Outperform |
InspireMD Inc. 주식(NSPR)의 최신 뉴스
StockNews.com Begins Coverage on InspireMD (NYSE:NSPR) - Defense World
StockNews.com Initiates Coverage on InspireMD (NYSE:NSPR) - Defense World
InspireMD at 24th Annual Needham: Strategic Moves in Healthcare By Investing.com - Investing.com Canada
InspireMD announces inducement grants under Nasdaq listing rule - TipRanks
Inspiremd Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
InspireMD Expands Team: 299K Shares Granted to New Medical Device Experts - Stock Titan
InspireMD files $200M mixed securities shelf - MSN
InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com - Defense World
InspireMD Inc Files For Mixed Shelf Of Up To $200 MillionSEC Filing - MarketScreener
InspireMD (NYSE:NSPR) Coverage Initiated at StockNews.com - Defense World
InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference - The Manila Times
InspireMD (NYSE:NSPR) & AngioDynamics (NASDAQ:ANGO) Head-To-Head Review - Defense World
Reviewing Anika Therapeutics (NASDAQ:ANIK) and InspireMD (NYSE:NSPR) - Defense World
InspireMD, Inc. (NSPR) Reports Q4 Loss, Tops Revenue Estimates - MSN
InspireMD, Inc. (NASDAQ:NSPR) Q4 2024 Earnings Call Transcript - Insider Monkey
InspireMD Inc (NSPR) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses and ... By GuruFocus - Investing.com Canada
InspireMD Inc. Reports 2024 Financial Results and Strategic Progress - TipRanks
InspireMD’s Earnings Call: Cautious Optimism Amid Challenges - TipRanks
InspireMD earnings beat by $0.01, revenue topped estimates - Investing.com Canada
Earnings call transcript: InspireMD Q4 2024 beats revenue forecast, stock rises - Investing.com India
InspireMD Inc reports results for the quarter ended December 31Earnings Summary - TradingView
InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
InspireMD reports Q4 EPS (19c) vs (16c) last year - TipRanks
INSPIREMD Earnings Results: $NSPR Reports Quarterly Earnings - Nasdaq
InspireMD Achieves Record $1.95M Revenue as FDA Approval Nears - StockTitan
InspireMD, Inc. SEC 10-K Report - TradingView
InspireMD (NYSE:NSPR) and Bluejay Diagnostics (NASDAQ:BJDX) Head to Head Survey - Defense World
InspireMD (NYSE:NSPR) Now Covered by StockNews.com - Defense World
InspireMD, Inc. to Host Earnings Call - ACCESS Newswire
InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
When Will InspireMD Release Its 2024 Results? Key Date for Carotid Stent Maker Announced - StockTitan
Is InspireMD's Hiring Spree a Signal for Investors? Company Awards 138K Shares to New Talent - StockTitan
Investors in InspireMD (NASDAQ:NSPR) have unfortunately lost 78% over the last five years - Yahoo
NSPR stock touches 52-week high at $3.43 amid robust growth - Investing.com
InspireMD and NAMSA to begin study of carotid stent system for TCAR procedures - Yahoo
InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal - GlobeNewswire
InspireMD And NAMSA To Partner On CGuardians II Pivotal Clinical Trial Of The CGuard Prime 80 Cm Carotid Stent System For Use In TCAR Procedures - Marketscreener.com
Major Clinical Trial Alert: InspireMD's Revolutionary TCAR Stent Targets $1B+ Market - StockTitan
Investors in InspireMD (NASDAQ:NSPR) from five years ago are still down 86%, even after 10% gain this past week - Simply Wall St
InspireMD Inc. (NSPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):